Copyright 2017-2020 Nutra Pharma Corporation. All Rights Reserved
SOLUTIONS
Pharmaceuticals
Nutra Pharma Corp. specializes in the acquisition, licensing, and commercialization of pharmaceutical products for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including multiple sclerosis (MS), human immunodeficiency virus (HIV), adrenomyeloneuropathy (AMN) and pain
OTC Homeopathics
Nutra Pharma Corp. offers homeopathic products for sale for the treatment of pain: Nyloxin®, the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain; Nyloxin Extra Strength®, the only non-narcotic and non-addictive treatment for severe (Stage 3) pain; Pet Pain-Away, an all-natural, pain reliever clinically proven to treat moderate to severe chronic pain in Dogs and Cats; and
Equine Pain-Away, an all-natural, topical pain reliever to treat pain and inflammation in Horses.
Copyright 2017-2020 Nutra Pharma Corporation. All Rights Reserved
ABOUT NUTRA PHARMA
Mission Statement
Nutra Pharma is dedicated to the success of its patients, customers, investors and business partners through its development and acquisition of innovative pharmaceutical and life science solutions that will improve the lives of people throughout the world.
Nutra Pharma Corp. (OTC: NPHC) Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin® and Pet Pain-Away™.
